¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2024³â ´ëÇѱÙÀüµµÀü±âÁø´ÜÀÇÇÐȸ Ãá°èÇмú´ëȸ : 2024-05-18

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

2024³â ´ëÇѱÙÀüµµÀü±âÁø´ÜÀÇÇÐȸ Ãá°èÇмú´ëȸ : 2024-05-18
±³À°ÀÏÀÚ : 2024-05-18
±³À°Àå¼Ò : »ï¼º¼­¿ïº´¿ø ¾Ïº´¿ø ÁöÇÏ1Ãþ ´ë°­´ç

±³À°ÁÖÁ¦ : 2024³â ´ëÇѱÙÀüµµÀü±âÁø´ÜÀÇÇÐȸ Ãá°èÇмú´ëȸ

ÁÖÃÖ±â°ü : ´ëÇѱÙÀüµµ¤ýÀü±âÁø´ÜÀÇÇÐȸ
´ã´çÀÚ : À±´Ù¼Ø
¿¬¶ôó : 02-3280-3085  

À̸ÞÀÏ : kanem.korea@outlook.com

±³À°Á¾·ù : ½Å°æ°ú, ÀçÈ°ÀÇÇаú

Âü¼®¿¹»óÀÎ : 120¸í
Èñ¸ÁÆòÁ¡ : 6Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 6 ½Ã°£ 0ºÐ

¼¼ºÎ¼ö°­·á : 120,000¿ø 

ºñ°í »çÀüµî·Ï- Á¤È¸¿ø 9¸¸¿ø- ÁØȸ¿ø 4¸¸¿ø- ºñȸ¿ø 10¸¸¿ø ÇöÀåµî·Ï- Á¤È¸¿ø 11¸¸¿ø- ÁØȸ¿ø 5¸¸¿ø- ºñȸ¿ø 12¸¸¿ø


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 05¿ù 18ÀÏ B1 ´ë°­´ç 09:10~09:30 Diagnostic approaches of idiopathic facial palsy (laboratory, electrodiagnostic and radiologic evaluations) ÀÌÇý¸²(°í·ÁÀÇ´ë ½Å°æ°ú)

±³À°½Ã°£ 05¿ù 18ÀÏ B1 ´ë°­´ç 09:30~09:50 Non-surgical managements of idiopathic facial palsy (pharmaceutical agents, botulinum toxin etc.) ±èÁø(ÇѸ²ÀÇ´ë À̺ñÀÎÈÄ°ú)

±³À°½Ã°£ 05¿ù 18ÀÏ B1 ´ë°­´ç 09:50~10:10 Reanimation surgery Á¤ÀºÀç(¼­¿ïÀÇ´ë À̺ñÀÎÈÄ°ú)

Åä·Ð 05¿ù 18ÀÏ B1 ´ë°­´ç 10:10~10:30 Q & A ()

ÈÞ½Ä 05¿ù 18ÀÏ B1 ´ë°­´ç 10:30~10:50 ÈÞ½Ä ()

±³À°½Ã°£ 05¿ù 18ÀÏ B1 ´ë°­´ç 10:50~11:15 "Axial (paraspinal) myopathy" is a definitive neuromuscular diagnosis ÀÌÀνÄ(ÆÄÁÖ½ÃƼº´¿ø ÀçÈ°ÀÇÇаú)

±³À°½Ã°£ 05¿ù 18ÀÏ B1 ´ë°­´ç 11:15~11:40 "Axial (paraspinal) myopathy" is a precursor of serious neuro-muscular disease ¹ÚÇüÁØ(¿¬¼¼ÀÇ´ë ½Å°æ°ú)

Åä·Ð 05¿ù 18ÀÏ B1 ´ë°­´ç 11:40~11:50 Q & A ()

±âŸ 05¿ù 18ÀÏ B1 ´ë°­´ç 11:50~12:00 ÃÑȸ ()

½Ä»ç 05¿ù 18ÀÏ B1 ´ë°­´ç 12:00~13:00 Á¡½É½Ã°£ ()

±³À°½Ã°£ 05¿ù 18ÀÏ B1 ´ë°­´ç 13:00~13:50 Current and future direction of molecular therapy for neuromuscular disorders ¹è»ó¼ö(¼­¿ïÀÇ´ë »ýÈ­Çб³½Ç)

±³À°½Ã°£ 05¿ù 18ÀÏ B1 ´ë°­´ç 13:50~14:35 A case of ANCA associated vasculitis presenting with lower extremity myositis ¼º´öÇö(»ï¼º¼­¿ïº´¿ø ÀçÈ°ÀÇÇаú )

±³À°½Ã°£ 05¿ù 18ÀÏ B1 ´ë°­´ç 14:35~15:20 Critical Illness Myopathy Associated with a Huge Ovarian Mass: A Rare case outside the Intensive Care Unit Setting ÀÌÇü¼ö(±¹¸³Áß¾ÓÀÇ·á¿ø)

ÈÞ½Ä 05¿ù 18ÀÏ B1 ´ë°­´ç 15:20~15:40 ÈÞ½Ä ()

±³À°½Ã°£ 05¿ù 18ÀÏ B1 ´ë°­´ç 15:40~16:00 Biomarkers and genetics in ALS ÃÖ¼®Áø(¼­¿ïÀÇ´ë ½Å°æ°ú)

±³À°½Ã°£ 05¿ù 18ÀÏ B1 ´ë°­´ç 16:00~16:20 Differential diagnosis of ALS and other neuromuscular disorder (clinical and neurophysiological view, TMS, MEP, imaging study, etc) À̵¿±Ô(¿µ³²ÀÇ´ë ÀçÈ°ÀÇÇаú)

±³À°½Ã°£ 05¿ù 18ÀÏ B1 ´ë°­´ç 16:20~16:40 Update on current ALS Therapies ÀÌ»ó°ï(Áß¾ÓÀÇ´ë ½Å°æ°ú)

±³À°½Ã°£ 05¿ù 18ÀÏ B1 ´ë°­´ç 16:40~17:00 Palliative care in ALS: Focusing on non-invasive ventilatory support Á¶ÇѾó(¿¬¼¼ÀÇ´ë ÀçÈ°ÀÇÇаú)

±âŸ 05¿ù 18ÀÏ B1 ´ë°­´ç 17:00~17:10 ½Ã»ó ¹× Æóȸ ()

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2024³â ´ëÇѱÙÀüµµÀü±âÁø´ÜÀÇÇÐȸ Ãá°èÇмú´ëȸ : 2024-05-18""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û 24³âµµ ´ëÇѱâ´ÉÀÇÇÐȸ Ãá°èÇмú´ëȸ : 2024-05-19
´ÙÀ½±Û ´ëÇÑ°¡Á¤ÀÇÇÐȸ ¼­¿ïÁöȸ ¿¬¼ö°­Á : 2024-05-18
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20897 ¼­¿ï ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ ENDO 2024 (Day2) : 2024-07-05 0 86 2024-05-28
20896 ¼­¿ï ÀÓ»ó¼ú±â±³À°¿¬±¸È¸ Á¦16ȸ ÀÓ»ó¼ú±â ¿¬¼ö°­Á : 2024-07-04 0 158 2024-05-28
20895 °æ±â ¿ëÀμ¼ºê¶õ½ºº´¿ø µðÁöÅÐÀÇ·á½ÉÆ÷Áö¾ö -¹Ì·¡ ÀǷḦ À§ÇÑ ±³·ù¿Í Çù·Â : 2024-07-04 0 118 2024-05-28
20894 ¼­¿ï ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ ENDO 2024 (Day1) : 2024-07-04 0 50 2024-05-28
20893 ¼­¿ï ´ëÇÑ»êºÎÀΰúÇÐȸ ¼­ºÎÁöȸ Á¤±â Áý´ãȸ(Àڱ󻸷Áõ½ÄÁõ) : 2024-07-02 0 69 2024-05-28
20892 ¼­¿ï ´ëÇѼҾƽÅÀåÇÐȸ (¿Â¶óÀÎ) 2024³â ¼Ò¾Æ½ÅÀå Post-graduate education course : 2024-07-01 0 46 2024-05-28
20891 ´ëÀü Ãæ³²´ëÇб³º´¿ø 2024³â °³¿øÀÇ¿Í ÇÔ²²ÇÏ´Â ³»°ú ¿¬¼ö°­Á : 2024-06-30 0 66 2024-05-28
20890 ¼­¿ï ´ëÇѳúÁ¹ÁßÇÐȸ 6¿ù º¸¼ö±³À° : 2024-06-30 0 166 2024-05-27
20889 ¼­¿ï (¿Â¶óÀÎ)Á¦22Â÷ ¼­¿ïƯº°½ÃÀÇ»çȸ Çмú´ëȸ : 2024-06-30 0 102 2024-05-27
20888 °æ±â (¿Â¶óÀÎ)Á¦21Â÷ °æ±âµµÀÇ»çȸ ¿Â¶óÀÎ Çмú´ëȸ : 2024-06-30 0 216 2024-05-27
20887 Àü³² 2024³â ´ëÇÑ´ëÀåÇ×¹®ÇÐȸ ¿¬¼ö°­Á : 2024-06-30 0 98 2024-05-27
20886 Ãæ³² ´ëÇÑÁ¤Çü¿Ü°úÃÊÀ½ÆÄÇÐȸ - Á¦19Â÷ Ãá°èÇмú´ëȸ ¹× Á¦38Â÷ ±Ù°ñ°Ý°è ÃÊÀ½ÆÄ¿öÅ©¼¥ (Basic Course) : 2024-06-30 0 49 2024-05-27
20885 ºÎ»ê Á¦3ȸ ´ëÇÑÅõ¼®Çùȸ ºÎ»êÁöȸ ½ÉÆ÷Áö¾ö : 2024-06-29 0 57 2024-05-27
20884 ¼­¿ï Çѱ¹ÁöÁú¤ýµ¿¸Æ°æÈ­ÇÐȸ Á¦7ȸ A to Z (Atherosclerosis to Zero) ¿¬¼ö°­Á ÇÁ·Î±×·¥ : 2024-06-29 0 83 2024-05-27
20883 °æ±â 2024³âµµ ³²¾çÁÖ½ÃÀÇ»çȸ Çмú´ëȸ : 2024-06-29 0 68 2024-05-27
21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷